| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |